Article Details

Factbox: Eisai-Biogen Alzheimer's drug success follows many failures - Reuters

Retrieved on: 2022-09-27 23:46:53

Tags for this article:

Click the tags to see associated articles and topics

Factbox: Eisai-Biogen Alzheimer's drug success follows many failures - Reuters. View article details on hiswai:

Excerpt

Roche (ROG.S) and Eli Lilly. gantenerumab, solanezumab. Combination failed to arrest cognitive decline in those afflicted by gene mutations.

Article found on: www.reuters.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up